Zobrazeno 1 - 3
of 3
pro vyhledávání: '"William N. William"'
Autor:
William N. William
Publikováno v:
Current Opinion in Oncology. 24:205-210
To discuss the recent advances in oral cancer risk prediction, as well as agents that have been or are currently being tested in clinical trials, to treat oral premalignant lesions (OPLs) and prevent oral cancers.Multiple predictive markers of OPL ma
Autor:
Edward S. Kim, Roy S. Herbst, Ralph Zinner, William N. William, J. Jack Lee, Frank V. Fossella, Scott M. Lippman, Bonnie S. Glisson, Fadlo R. Khuri
Publikováno v:
American Journal of Clinical Oncology. 33:148-152
Objectives: Combination chemotherapy with third-generation, nonplatinum agents (ie, gemcitabine, vinorelbine, taxanes, or camptothecins) represents a well-tolerated frontline treatment option for metastatic non―small-cell lung cancer and might play
Autor:
Waun Ki Hong, Joseph Lee, J. Jack Lee, Dong M. Shin, William N. William, Edward S. Kim, Suyu Liu, Scott M. Lippman, Fadlo R. Khuri
Publikováno v:
American Journal of Clinical Oncology. 32:15-19
Objective: This phase I trial was designed to determine the maximal tolerated dose (MTD) of the combination of topotecan and gemcitabine given in a weekly schedule. Materials and Methods: In this single-arm, open label, dose-escalation study, we admi